Star Gold appoints Tom Power as COO (SRGZ:OTCMKTS)

Star Gold (SRGZ) named Tom Power as its new chief operating officer. Power previously led Sunshine Minting for nearly 20 years and started his career at Johnson Matthey's Canadian division. The appointment may signal strategic changes for the company.

Original reporting
Published Oct 6, 2026, 12:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SRGZ
Neutral
medium confidence
Mentioned
$SRGZ
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$SRGZNeutralLow
01

Why it matters

The COO appointment is a standard corporate update with limited immediate price effect.

02

Market read

Routine executive change with low trading relevance.

03

What to watch

Tom Power's experience may improve operational efficiency over time.

Relevance 7/10Novelty 6/10Timing: today

Background

Star Gold is a junior gold mining company listed on the OTC market.

Company-level read

Ticker impact

$SRGZNeutralMedium confidence
Context

Star Gold announced the appointment of Tom Power as chief operating officer.

Expected impact

neutral

Evidence & confidence

New COO hire is a routine corporate action; market reaction is likely limited.

Market effects

Minimal impact on the gold mining sector.

Limited to investors tracking Star Gold.

Low

Counterpoint

The appointment could signal strategic shifts not yet disclosed.

Key entities

  • Star Gold

    Gold mining firm (OTC: SRGZ).

  • Tom Power

    New chief operating officer.

Related articles

$NNVCMed

NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox

NanoViricides, Inc. (NYSE American:NNVC) filed its Q3 2026 report, revealing Phase II trials for NV-387 Oral Gummies to treat Ebola and Mpox. The company has $2.98M in cash and $9.56M in total assets, but warns of insufficient funding for operations beyond November 2027.

$UBERMed

Kohl’s products now available for delivery on Uber Eats

Uber (UBER) and Kohl's (KSS) partnered to offer Kohl's products via Uber Eats, covering 1,100+ U.S. stores. Items include apparel, home goods, and Sephora beauty products. The service launches before the holiday season, with a $10 discount on first orders over $50 until December 3, 2026. Kohl's operates 1,100+ stores in 49 states.

$SPCBMed

SuperCom Wins 2nd Electronic Monitoring Contract in Indiana, Fully Displacing Incumbent Provider

SuperCom (SPCB) won its second electronic monitoring contract in Indiana, replacing an incumbent provider. The deal involves deploying its PureSecurity suite, with rollout starting in December 2026. The company reported a trailing twelve-month EBITDA of approximately $12.1 million through Q3 2026, citing over 50 new U.S. contracts and 20 national project wins in Europe since mid-2024.

$NKEMed

Nike unveils growth strategy, targets $5B revenue increase by 2031

Nike (NKE) unveiled its Full Stride Ahead strategy, targeting $5B in incremental revenue growth by 2031. The company expects fiscal 2027 revenue to decline in the high-single digits, with adjusted earnings per share of $1.15-$1.35. By 2031, Nike aims for operating margins of 12-14% and adjusted EPS of $3.00-$3.50, with Performance Sports and Sportswear driving growth. Nike plans to return $12B to shareholders through dividends by 2031.